Faeth Therapeutics, Inc. (FTH)
NASDAQ: FTH · Real-Time Price · USD
40.05
+1.05 (2.69%)
At close: Sep 4, 2026, 4:00 PM EDT
40.50
+0.45 (1.12%)
After-hours: Sep 4, 2026, 7:30 PM EDT
Faeth Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
29
Market Cap
1.03B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2010 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2008 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Geron | 204.56M |
| Arbutus Biopharma | 181.72M |
| Lexicon Pharmaceuticals | 41.47M |
| Adlai Nortye Group | 18.06M |
| Inventiva | 7.94M |
| Avalo Therapeutics | 59.00K |
FTH News
- 4 days ago - Faeth Therapeutics to Participate in Upcoming September Investor Conferences - Business Wire
- 8 days ago - Faeth Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 15 days ago - Faeth Therapeutics initiated with a Buy at Needham - TheFly
- 19 days ago - Faeth Therapeutics granted Fast Track desingation for PIKTOR plus Paclitaxel - TheFly
- 19 days ago - Faeth Therapeutics Announces FDA Grant of Fast Track Designation for PIKTOR Plus Paclitaxel in Biomarker-Selected Advanced Endometrial Cancer - Business Wire
- 20 days ago - Faeth Therapeutics appoints Tiwari, Biegler as Senior Vice Presidents - TheFly
- 22 days ago - Faeth Therapeutics Strengthens Executive Team with Senior Leadership Appointments - Business Wire
- 4 weeks ago - Faeth Therapeutics to Present PK/PD Modeling That Informed PIKTOR Dose Selection in Ongoing FTH-PIK-201 Trial at Upcoming Scientific Conference - Business Wire